The risk or severity of adverse effects can be increased when cabergoline is combined with Repaglinide.


The risk or severity of adverse effects can be increased when Mephobarbital is combined with Oxybuprocaine.


The risk or severity of adverse effects can be increased when zonisamide is combined with Levetiracetam.


The risk or severity of adverse effects can be increased when cabergoline is combined with metronidazole.


The risk or severity of adverse effects can be increased when enalapril is combined with diclofenac.


The risk or severity of adverse effects can be increased when cabergoline is combined with Almotriptan.


The risk or severity of adverse effects can be increased when METAXALONE is combined with fluoxetine.


The risk or severity of adverse effects can be increased when bupivacaine is combined with carisoprodol.


The risk or severity of adverse effects can be increased when Fencamfamin is combined with Tasimelteon.


The risk or severity of adverse effects can be increased when METAXALONE is combined with duloxetine.


The risk or severity of adverse effects can be increased when furosemide is combined with risperidone.


The risk or severity of adverse effects can be increased when arsenic trioxide is combined with reserpine.


The risk or severity of adverse effects can be increased when meperidine is combined with butamben.


The risk or severity of adverse effects can be increased when Ziprasidone is combined with 4-Hydroxybutanoic acid.


The risk or severity of adverse effects can be increased when carprofen is combined with flunisolide.


The risk or severity of adverse effects can be increased when orphenadrine is combined with Propiverine.


The risk or severity of adverse effects can be increased when ketorolac is combined with Fluprednidene.


The risk or severity of adverse effects can be increased when ketorolac is combined with FLUOCORTOLONE.


The risk or severity of adverse effects can be increased when fenbufen is combined with Estrone sulfate.


The risk or severity of adverse effects can be increased when tacrolimus is combined with Dimethyl fumarate.


The risk or severity of adverse effects can be increased when amitriptyline is combined with cetirizine.


The risk or severity of adverse effects can be increased when AMILORIDE is combined with DEXMEDETOMIDINE.


The risk or severity of adverse effects can be increased when imipramine is combined with ARBUTAMINE.


The risk or severity of adverse effects can be increased when nitrous oxide is combined with BREXPIPRAZOLE.


The risk or severity of adverse effects can be increased when Propacetamol is combined with CLOCORTOLONE.


The risk or severity of adverse effects can be increased when protriptyline is combined with METAXALONE.


The risk or severity of adverse effects can be increased when Olopatadine is combined with triamcinolone.


The risk or severity of adverse effects can be increased when tolmetin is combined with Teriflunomide.


The risk or severity of adverse effects can be increased when thiamylal is combined with CYPROHEPTADINE.


The risk or severity of adverse effects can be increased when METHOHEXITAL is combined with Levomilnacipran.


The risk or severity of adverse effects can be increased when diclofenac is combined with DESMOPRESSIN.


The risk or severity of adverse effects can be increased when BISOPROLOL is combined with hydrochlorothiazide.


The risk or severity of adverse effects can be increased when flumethasone is combined with sparfloxacin.


The risk or severity of adverse effects can be increased when METHOHEXITAL is combined with Pomalidomide.


The risk or severity of adverse effects can be increased when MOEXIPRIL is combined with Naftifine.


The risk or severity of adverse effects can be increased when midazolam is combined with desipramine.


The risk or severity of adverse effects can be increased when Naftifine is combined with PAMIDRONIC ACID.


The risk or severity of adverse effects can be increased when primidone is combined with Milnacipran.


The risk or severity of adverse effects can be increased when FLUTICASONE PROPIONATE is combined with ethosuximide.


The risk or severity of adverse effects can be increased when mycophenolate mofetil is combined with CLOCORTOLONE.


The risk or severity of adverse effects can be increased when Pentolinium is combined with Fesoterodine.


The risk or severity of adverse effects can be increased when Naftifine is combined with amcinonide.


The risk or severity of adverse effects can be increased when Perospirone is combined with Tasimelteon.


The risk or severity of adverse effects can be increased when hydromorphone is combined with etizolam.


The risk or severity of adverse effects can be increased when loxapine is combined with Flibanserin.


The risk or severity of adverse effects can be increased when oxyphenbutazone is combined with RIMEXOLONE.


The risk or severity of adverse effects can be increased when resveratrol is combined with Clodronic Acid.


The risk or severity of adverse effects can be increased when brotizolam is combined with phenytoin.


The risk or severity of adverse effects can be increased when sulpiride is combined with Pomalidomide.


The risk or severity of adverse effects can be increased when Sertaconazole is combined with simvastatin.


The risk or severity of adverse effects can be increased when Torasemide is combined with hydrochlorothiazide.


The risk or severity of adverse effects can be increased when nicergoline is combined with Enasidenib.


The risk or severity of adverse effects can be increased when chloral hydrate is combined with citalopram.


The risk or severity of adverse effects can be increased when tretinoin is combined with terazosin.


The risk or severity of adverse effects can be increased when butalbital is combined with DIMENHYDRINATE.


The risk or severity of adverse effects can be increased when quetiapine is combined with zotepine.


The risk or severity of adverse effects can be increased when quetiapine is combined with MELPERONE.


The risk or severity of adverse effects can be increased when butalbital is combined with Ramelteon.


The risk or severity of adverse effects can be increased when bepridil is combined with DESFLURANE.


The risk or severity of adverse effects can be increased when diazepam is combined with perphenazine.


The risk or severity of adverse effects can be increased when apomorphine is combined with Efonidipine.


The risk or severity of adverse effects can be increased when diazepam is combined with levorphanol.


The risk or severity of adverse effects can be increased when Voriconazole is combined with Risedronic acid.


The risk or severity of adverse effects can be increased when clopidogrel is combined with mesalamine.


The risk or severity of adverse effects can be increased when tolmetin is combined with Propacetamol.


The risk or severity of adverse effects can be increased when Olmesartan is combined with timolol.


The risk or severity of adverse effects can be increased when procyclidine is combined with mecamylamine.


The risk or severity of adverse effects can be increased when tropicamide is combined with ANISOTROPINE METHYLBROMIDE.


The risk or severity of adverse effects can be increased when bromocriptine is combined with cisapride.


The risk or severity of adverse effects can be increased when buspirone is combined with ethosuximide.


The risk or severity of adverse effects can be increased when salicylamide is combined with fludrocortisone.


The risk or severity of adverse effects can be increased when selegiline is combined with Pipotiazine.


The risk or severity of adverse effects can be increased when cocaine is combined with tetracaine.


The risk or severity of adverse effects can be increased when ethanol is combined with acetohydroxamic acid.


The risk or severity of adverse effects can be increased when methylergonovine is combined with Bortezomib.


The risk or severity of adverse effects can be increased when Arotinolol is combined with furosemide.


The risk or severity of adverse effects can be increased when Arotinolol is combined with phentolamine.


The risk or severity of adverse effects can be increased when Arotinolol is combined with MOEXIPRIL.


The risk or severity of adverse effects can be increased when Naftifine is combined with diflunisal.


The risk or severity of adverse effects can be increased when secobarbital is combined with METAXALONE.


The risk or severity of adverse effects can be increased when resveratrol is combined with dexamethasone.


The risk or severity of adverse effects can be increased when methysergide is combined with clozapine.


The risk or severity of adverse effects can be increased when VALPROIC ACID is combined with amisulpride.


The risk or severity of adverse effects can be increased when methysergide is combined with vinorelbine.


The risk or severity of adverse effects can be increased when prilocaine is combined with Difenoxin.


The risk or severity of adverse effects can be increased when Aripiprazole is combined with dibucaine.


The risk or severity of adverse effects can be increased when oxymorphone is combined with carisoprodol.


The risk or severity of adverse effects can be increased when oxymorphone is combined with sulpiride.


The risk or severity of adverse effects can be increased when phenoxybenzamine is combined with Ropivacaine.


The risk or severity of adverse effects can be increased when moclobemide is combined with Paliperidone.


The risk or severity of adverse effects can be increased when tetracaine is combined with Flibanserin.


The risk or severity of adverse effects can be increased when apomorphine is combined with GUANFACINE.


The risk or severity of adverse effects can be increased when Tramadol is combined with estazolam.


The risk or severity of adverse effects can be increased when sevoflurane is combined with D-mannitol.


The risk or severity of adverse effects can be increased when floctafenine is combined with Teriflunomide.


The risk or severity of adverse effects can be increased when Pipamperone is combined with sotalol.


The risk or severity of adverse effects can be increased when benzocaine is combined with Normethadone.


The risk or severity of adverse effects can be increased when triamterene is combined with methyldopa.


The risk or severity of adverse effects can be increased when aspirin is combined with paramethasone.


The risk or severity of adverse effects can be increased when methylergonovine is combined with loratadine.


The risk or severity of adverse effects can be increased when aspirin is combined with CORTISONE ACETATE.


The risk or severity of adverse effects can be increased when methysergide is combined with Isavuconazonium.


The risk or severity of adverse effects can be increased when Levobupivacaine is combined with scopolamine.


The risk or severity of adverse effects can be increased when chloroquine is combined with desoximetasone.


The risk or severity of adverse effects can be increased when Aripiprazole is combined with Etomidate.


The risk or severity of adverse effects can be increased when ADAPALENE is combined with oxaprozin.


The risk or severity of adverse effects can be increased when nilvadipine is combined with Empagliflozin.


The risk or severity of adverse effects can be increased when nabumetone is combined with flurandrenolide.


The risk or severity of adverse effects can be increased when fluocinonide is combined with Gemifloxacin.


The risk or severity of adverse effects can be increased when Pregabalin is combined with Magnesium salicylate.


The risk or severity of adverse effects can be increased when BENZYDAMINE is combined with CLOCORTOLONE.


The risk or severity of adverse effects can be increased when phenobarbital is combined with butalbital.


The risk or severity of adverse effects can be increased when Etidocaine is combined with brotizolam.


The risk or severity of adverse effects can be increased when phenylephrine is combined with epinephrine.


The risk or severity of adverse effects can be increased when oxaprozin is combined with Dehydroepiandrosterone.


The risk or severity of adverse effects can be increased when Fosaprepitant is combined with atorvastatin.


The risk or severity of adverse effects can be increased when bupivacaine is combined with Hexobarbital.


The risk or severity of adverse effects can be increased when imipramine is combined with terbutaline.


The risk or severity of adverse effects can be increased when loxapine is combined with Zuclopenthixol.


The risk or severity of adverse effects can be increased when Pipamperone is combined with meclizine.


The risk or severity of adverse effects can be increased when Etoricoxib is combined with hydrocortisone.


The risk or severity of adverse effects can be increased when clotrimazole is combined with felodipine.


The risk or severity of adverse effects can be increased when propoxyphene is combined with oxprenolol.


The risk or severity of adverse effects can be increased when clidinium is combined with Flibanserin.


The risk or severity of adverse effects can be increased when loxapine is combined with thiothixene.


The risk or severity of adverse effects can be increased when meprobamate is combined with GUANFACINE.


The risk or severity of adverse effects can be increased when haloperidol is combined with Tolcapone.


The risk or severity of adverse effects can be increased when propoxyphene is combined with prazepam.


The risk or severity of adverse effects can be increased when olanzapine is combined with fexofenadine.


The risk or severity of adverse effects can be increased when valsartan is combined with penbutolol.


The risk or severity of adverse effects can be increased when doxycycline is combined with Flibanserin.


The risk or severity of adverse effects can be increased when isoflurane is combined with Olopatadine.


The risk or severity of adverse effects can be increased when Miltefosine is combined with felodipine.


The risk or severity of adverse effects can be increased when Torasemide is combined with Bretylium.


The risk or severity of adverse effects can be increased when HEROIN is combined with maprotiline.


The risk or severity of adverse effects can be increased when triprolidine is combined with METAXALONE.


The risk or severity of adverse effects can be increased when dicyclomine is combined with DIHYDROCODEINE.


The risk or severity of adverse effects can be increased when Clofarabine is combined with tretinoin.


The risk or severity of adverse effects can be increased when valsartan is combined with triamterene.


The risk or severity of adverse effects can be increased when trihexyphenidyl is combined with tropicamide.


The risk or severity of adverse effects can be increased when Metixene is combined with ALFENTANIL.


The risk or severity of adverse effects can be increased when levorphanol is combined with trazodone.


The risk or severity of adverse effects can be increased when diclofenac is combined with tolfenamic acid.


The risk or severity of adverse effects can be increased when Telaprevir is combined with meperidine.


The risk or severity of adverse effects can be increased when diclofenac is combined with Droxicam.


The risk or severity of adverse effects can be increased when diclofenac is combined with Loxoprofen.


The risk or severity of adverse effects can be increased when tiapride is combined with Dexbrompheniramine.


The risk or severity of adverse effects can be increased when methoxamine is combined with hydroxyamphetamine.


The risk or severity of adverse effects can be increased when amiodarone is combined with Eprosartan.


The risk or severity of adverse effects can be increased when chlorzoxazone is combined with vigabatrin.


The risk or severity of adverse effects can be increased when isocarboxazid is combined with ropinirole.


The risk or severity of adverse effects can be increased when apomorphine is combined with indapamide.


The risk or severity of adverse effects can be increased when Caspofungin is combined with Clevidipine.


The risk or severity of adverse effects can be increased when sulindac is combined with aspirin.


The risk or severity of adverse effects can be increased when apomorphine is combined with fenoldopam.


The risk or severity of adverse effects can be increased when Aceprometazine is combined with efavirenz.


The risk or severity of adverse effects can be increased when AZILSARTAN MEDOXOMIL is combined with Riociguat.


The risk or severity of adverse effects can be increased when glutethimide is combined with chlorzoxazone.


The risk or severity of adverse effects can be increased when diphenhydramine is combined with Olopatadine.


The risk or severity of adverse effects can be increased when triprolidine is combined with ethosuximide.


The risk or severity of adverse effects can be increased when ANISOTROPINE METHYLBROMIDE is combined with buprenorphine.


The risk or severity of adverse effects can be increased when pentamidine is combined with isradipine.


The risk or severity of adverse effects can be increased when tretinoin is combined with Empagliflozin.


The risk or severity of adverse effects can be increased when aspirin is combined with DESMOPRESSIN.


The risk or severity of adverse effects can be increased when flurbiprofen is combined with homoharringtonine.


The risk or severity of adverse effects can be increased when niflumic acid is combined with amcinonide.


The risk or severity of adverse effects can be increased when phenoxybenzamine is combined with D-mannitol.


The risk or severity of adverse effects can be increased when sulindac is combined with leflunomide.


The risk or severity of adverse effects can be increased when butorphanol is combined with Alvimopan.


The risk or severity of adverse effects can be increased when METHOHEXITAL is combined with SUFENTANIL.


The risk or severity of adverse effects can be increased when MAGNESIUM SULFATE is combined with atorvastatin.


The risk or severity of adverse effects can be increased when fluoxetine is combined with ERGOTAMINE.


The risk or severity of adverse effects can be increased when ethopropazine is combined with Butylscopolamine.


The risk or severity of adverse effects can be increased when Eletriptan is combined with risperidone.


The risk or severity of adverse effects can be increased when mefenamic acid is combined with PAMIDRONIC ACID.


The risk or severity of adverse effects can be increased when epirizole is combined with fluocinonide.


The risk or severity of adverse effects can be increased when Phenelzine is combined with Isometheptene.


The risk or severity of adverse effects can be increased when fenbufen is combined with flumethasone.


The risk or severity of adverse effects can be increased when chloroquine is combined with Dehydroepiandrosterone.


The risk or severity of adverse effects can be increased when mefenamic acid is combined with amcinonide.


The risk or severity of adverse effects can be increased when quetiapine is combined with vigabatrin.


The risk or severity of adverse effects can be increased when Eszopiclone is combined with GUANFACINE.


The risk or severity of adverse effects can be increased when nilvadipine is combined with dipyridamole.


The risk or severity of adverse effects can be increased when tiaprofenic acid is combined with Icatibant.


The risk or severity of adverse effects can be increased when Normethadone is combined with moclobemide.


The risk or severity of adverse effects can be increased when Atracurium besylate is combined with Tapentadol.


The risk or severity of adverse effects can be increased when DESFLURANE is combined with promethazine.


The risk or severity of adverse effects can be increased when DESFLURANE is combined with clonazepam.


The risk or severity of adverse effects can be increased when Normethadone is combined with CYCLIZINE.


The risk or severity of adverse effects can be increased when NITROUS ACID is combined with metoprolol.


The risk or severity of adverse effects can be increased when triazolam is combined with estazolam.


The risk or severity of adverse effects can be increased when mirtazapine is combined with Cariprazine.


The risk or severity of adverse effects can be increased when triazolam is combined with dantrolene.


The risk or severity of adverse effects can be increased when Nilotinib is combined with atorvastatin.


The risk or severity of adverse effects can be increased when SAQUINAVIR is combined with meperidine.


The risk or severity of adverse effects can be increased when bromocriptine is combined with Bretylium.


The risk or severity of adverse effects can be increased when nalbuphine is combined with nitrous oxide.


The risk or severity of adverse effects can be increased when felbamate is combined with paroxetine.


The risk or severity of adverse effects can be increased when Artemether is combined with gabapentin.


The risk or severity of adverse effects can be increased when ERGOTAMINE is combined with Ticagrelor.


The risk or severity of adverse effects can be increased when ERGOTAMINE is combined with Lurasidone.


The risk or severity of adverse effects can be increased when propoxyphene is combined with bumetanide.


The risk or severity of adverse effects can be increased when lidocaine is combined with DEXMEDETOMIDINE.


The risk or severity of adverse effects can be increased when amisulpride is combined with METAXALONE.


The risk or severity of adverse effects can be increased when TRICHLOROETHYLENE is combined with Milnacipran.


The risk or severity of adverse effects can be increased when reserpine is combined with quinidine.


The risk or severity of adverse effects can be increased when triamterene is combined with mecamylamine.


The risk or severity of adverse effects can be increased when cilazapril is combined with cyclophosphamide.


The risk or severity of adverse effects can be increased when thalidomide is combined with terazosin.


The risk or severity of adverse effects can be increased when trandolapril is combined with methyldopa.


The risk or severity of adverse effects can be increased when SERTINDOLE is combined with Articaine.


The risk or severity of adverse effects can be increased when trandolapril is combined with apraclonidine.


The risk or severity of adverse effects can be increased when zolmitriptan is combined with Phenelzine.


The risk or severity of adverse effects can be increased when ZILEUTON is combined with Lumiracoxib.


The risk or severity of adverse effects can be increased when risperidone is combined with Levetiracetam.


The risk or severity of adverse effects can be increased when isoflurane is combined with nefazodone.


The risk or severity of adverse effects can be increased when propofol is combined with nortriptyline.


The risk or severity of adverse effects can be increased when propofol is combined with amoxapine.


The risk or severity of adverse effects can be increased when propofol is combined with benazepril.


The risk or severity of adverse effects can be increased when isoflurane is combined with doxepin.


The risk or severity of adverse effects can be increased when risperidone is combined with DEZOCINE.


The risk or severity of adverse effects can be increased when SUFENTANIL is combined with clidinium.


The risk or severity of adverse effects can be increased when Aceprometazine is combined with Oxetacaine.


The risk or severity of adverse effects can be increased when isoflurane is combined with dichlorphenamide.


The risk or severity of adverse effects can be increased when chloroquine is combined with acemetacin.


The risk or severity of adverse effects can be increased when butalbital is combined with TETRABENAZINE.


The risk or severity of adverse effects can be increased when HEROIN is combined with QUINETHAZONE.


The risk or severity of adverse effects can be increased when Butethal is combined with Levomilnacipran.


The risk or severity of adverse effects can be increased when codeine is combined with clonidine.


The risk or severity of adverse effects can be increased when HEROIN is combined with Fosphenytoin.


The risk or severity of adverse effects can be increased when tenoxicam is combined with nimesulide.


The risk or severity of adverse effects can be increased when procyclidine is combined with Vecuronium.


The risk or severity of adverse effects can be increased when apomorphine is combined with thalidomide.


The risk or severity of adverse effects can be increased when BENDROFLUMETHIAZIDE is combined with Clevidipine.


The risk or severity of adverse effects can be increased when Eszopiclone is combined with pentazocine.


The risk or severity of adverse effects can be increased when amphotericin b is combined with quetiapine.


The risk or severity of adverse effects can be increased when mesalamine is combined with DESMOPRESSIN.


The risk or severity of adverse effects can be increased when Eszopiclone is combined with trazodone.


The risk or severity of adverse effects can be increased when reserpine is combined with cocaine.


The risk or severity of adverse effects can be increased when fludrocortisone is combined with rivastigmine.


The risk or severity of adverse effects can be increased when Sacubitril is combined with hydrochlorothiazide.


The risk or severity of adverse effects can be increased when ketorolac is combined with ADAPALENE.


The risk or severity of adverse effects can be increased when prilocaine is combined with SERTINDOLE.


The risk or severity of adverse effects can be increased when etizolam is combined with citalopram.


The risk or severity of adverse effects can be increased when Olmesartan is combined with Nebivolol.


The risk or severity of adverse effects can be increased when flurazepam is combined with Pramocaine.


The risk or severity of adverse effects can be increased when Sacubitril is combined with oxaprozin.


The risk or severity of adverse effects can be increased when doxepin is combined with Lorcaserin.


The risk or severity of adverse effects can be increased when bromazepam is combined with tranylcypromine.


The risk or severity of adverse effects can be increased when bromazepam is combined with prilocaine.


The risk or severity of adverse effects can be increased when DEXKETOPROFEN is combined with Teriflunomide.


The risk or severity of adverse effects can be increased when bromazepam is combined with ethotoin.


The risk or severity of adverse effects can be increased when formestane is combined with memantine.


The risk or severity of adverse effects can be increased when TASOSARTAN is combined with floctafenine.


The risk or severity of adverse effects can be increased when Loxoprofen is combined with desoximetasone.


The risk or severity of adverse effects can be increased when lorazepam is combined with Gabapentin enacarbil.


The risk or severity of adverse effects can be increased when gabapentin is combined with pimozide.


The risk or severity of adverse effects can be increased when Flupentixol is combined with Desloratadine.


The risk or severity of adverse effects can be increased when Etomidate is combined with Olopatadine.


The risk or severity of adverse effects can be increased when nitrazepam is combined with felbamate.


The risk or severity of adverse effects can be increased when MOEXIPRIL is combined with Apremilast.


The risk or severity of adverse effects can be increased when nalbuphine is combined with thiopental.


The risk or severity of adverse effects can be increased when butamben is combined with Oxetacaine.


The risk or severity of adverse effects can be increased when indapamide is combined with Telmisartan.


The risk or severity of adverse effects can be increased when quinapril is combined with hydralazine.


The risk or severity of adverse effects can be increased when indapamide is combined with methyldopa.


The risk or severity of adverse effects can be increased when nalbuphine is combined with AMILORIDE.


The risk or severity of adverse effects can be increased when Methadyl acetate is combined with ethotoin.


The risk or severity of adverse effects can be increased when ropinirole is combined with ramipril.


The risk or severity of adverse effects can be increased when nalbuphine is combined with ethosuximide.


The risk or severity of adverse effects can be increased when Lisdexamfetamine is combined with procarbazine.


The risk or severity of adverse effects can be increased when halothane is combined with mecamylamine.


The risk or severity of adverse effects can be increased when ipratropium is combined with Atracurium besylate.


The risk or severity of adverse effects can be increased when morniflumate is combined with fenoprofen.


The risk or severity of adverse effects can be increased when methysergide is combined with norfloxacin.


The risk or severity of adverse effects can be increased when ondansetron is combined with tetracaine.


The risk or severity of adverse effects can be increased when floctafenine is combined with Tiludronic Acid.


The risk or severity of adverse effects can be increased when floctafenine is combined with PREDNICARBATE.


The risk or severity of adverse effects can be increased when trihexyphenidyl is combined with nalbuphine.


The risk or severity of adverse effects can be increased when norepinephrine is combined with epinephrine.


The risk or severity of adverse effects can be increased when MOLINDONE is combined with primidone.


The risk or severity of adverse effects can be increased when Pipamperone is combined with tiapride.


The risk or severity of adverse effects can be increased when butenafine is combined with PERHEXILINE.


The risk or severity of adverse effects can be increased when lorazepam is combined with chlormezanone.


The risk or severity of adverse effects can be increased when Eplerenone is combined with dichlorphenamide.


The risk or severity of adverse effects can be increased when DIHYDROCODEINE is combined with Torasemide.


The risk or severity of adverse effects can be increased when lidocaine is combined with Remoxipride.


The risk or severity of adverse effects can be increased when ESMOLOL is combined with enalapril.


The risk or severity of adverse effects can be increased when benzyl alcohol is combined with ethosuximide.


The risk or severity of adverse effects can be increased when maprotiline is combined with Cariprazine.


The risk or severity of adverse effects can be increased when Pipamperone is combined with Propoxycaine.


The risk or severity of adverse effects can be increased when Toloxatone is combined with Salbutamol.


The risk or severity of adverse effects can be increased when azelastine is combined with paramethasone.


The risk or severity of adverse effects can be increased when zotepine is combined with Pomalidomide.


The risk or severity of adverse effects can be increased when apomorphine is combined with nimodipine.


The risk or severity of adverse effects can be increased when dibucaine is combined with Pipotiazine.


The risk or severity of adverse effects can be increased when trandolapril is combined with PIRFENIDONE.


The risk or severity of adverse effects can be increased when butabarbital is combined with ALFENTANIL.


The risk or severity of adverse effects can be increased when butabarbital is combined with Halazepam.


The risk or severity of adverse effects can be increased when trandolapril is combined with Etoricoxib.


The risk or severity of adverse effects can be increased when butabarbital is combined with proparacaine.


The risk or severity of adverse effects can be increased when Lornoxicam is combined with CORTISONE ACETATE.


The risk or severity of adverse effects can be increased when Lornoxicam is combined with paramethasone.


The risk or severity of adverse effects can be increased when Lormetazepam is combined with Flibanserin.


The risk or severity of adverse effects can be increased when amisulpride is combined with dantrolene.


The risk or severity of adverse effects can be increased when azelastine is combined with DEFLAZACORT.


The risk or severity of adverse effects can be increased when tenoxicam is combined with dexamethasone.


The risk or severity of adverse effects can be increased when SUFENTANIL is combined with 4-Hydroxybutanoic acid.


The risk or severity of adverse effects can be increased when fludiazepam is combined with venlafaxine.


The risk or severity of adverse effects can be increased when Efonidipine is combined with MAGNESIUM HYDROXIDE.


The risk or severity of adverse effects can be increased when NITROUS ACID is combined with nadolol.


The risk or severity of adverse effects can be increased when methyclothiazide is combined with digitoxin.


The risk or severity of adverse effects can be increased when DESFLURANE is combined with Enalaprilat.


The risk or severity of adverse effects can be increased when ipratropium is combined with Tramadol.


The risk or severity of adverse effects can be increased when NATAMYCIN is combined with tolfenamic acid.


The risk or severity of adverse effects can be increased when Aclidinium is combined with meperidine.


The risk or severity of adverse effects can be increased when Phenelzine is combined with mesoridazine.


The risk or severity of adverse effects can be increased when Phenelzine is combined with maprotiline.


The risk or severity of adverse effects can be increased when sulfadimethoxine is combined with mecamylamine.


The risk or severity of adverse effects can be increased when morniflumate is combined with antipyrine.


The risk or severity of adverse effects can be increased when TRICHLOROETHYLENE is combined with amoxapine.


The risk or severity of adverse effects can be increased when Methadyl acetate is combined with vigabatrin.


The risk or severity of adverse effects can be increased when ketamine is combined with Articaine.


The risk or severity of adverse effects can be increased when Phenelzine is combined with thalidomide.


The risk or severity of adverse effects can be increased when terazosin is combined with Empagliflozin.


The risk or severity of adverse effects can be increased when ALFENTANIL is combined with Ketobemidone.


The risk or severity of adverse effects can be increased when DEZOCINE is combined with clonazepam.


The risk or severity of adverse effects can be increased when DEZOCINE is combined with promethazine.


The risk or severity of adverse effects can be increased when apomorphine is combined with nifedipine.


The risk or severity of adverse effects can be increased when amobarbital is combined with Levobupivacaine.


The risk or severity of adverse effects can be increased when quetiapine is combined with fexofenadine.


The risk or severity of adverse effects can be increased when Halazepam is combined with KETAZOLAM.


The risk or severity of adverse effects can be increased when LISURIDE is combined with TROLEANDOMYCIN.


The risk or severity of adverse effects can be increased when pentazocine is combined with METHSUXIMIDE.


The risk or severity of adverse effects can be increased when antipyrine is combined with fluocinonide.


The risk or severity of adverse effects can be increased when carisoprodol is combined with Desloratadine.


The risk or severity of adverse effects can be increased when Zuclopenthixol is combined with FLUTICASONE PROPIONATE.


The risk or severity of adverse effects can be increased when morphine is combined with Lurasidone.


The risk or severity of adverse effects can be increased when Enalaprilat is combined with BALSALAZIDE.


The risk or severity of adverse effects can be increased when thiamylal is combined with chloral hydrate.


The risk or severity of adverse effects can be increased when dibucaine is combined with clonidine.


The risk or severity of adverse effects can be increased when thiamylal is combined with fludiazepam.


The risk or severity of adverse effects can be increased when Rufinamide is combined with Olopatadine.


The risk or severity of adverse effects can be increased when salicylamide is combined with RIMEXOLONE.


The risk or severity of adverse effects can be increased when methylene blue is combined with ritodrine.


The risk or severity of adverse effects can be increased when apomorphine is combined with papaverine.


The risk or severity of adverse effects can be increased when oxazepam is combined with clonazepam.


The risk or severity of adverse effects can be increased when oxazepam is combined with promethazine.


The risk or severity of adverse effects can be increased when haloprogin is combined with Pregabalin.


The risk or severity of adverse effects can be increased when Lacidipine is combined with methazolamide.


The risk or severity of adverse effects can be increased when Lacidipine is combined with Eplerenone.


The risk or severity of adverse effects can be increased when DIHYDROCODEINE is combined with TRICHLOROETHYLENE.


The risk or severity of adverse effects can be increased when oxazepam is combined with Melatonin.


The risk or severity of adverse effects can be increased when Lacidipine is combined with SUFENTANIL.


The risk or severity of adverse effects can be increased when Etoricoxib is combined with BENZYDAMINE.


The risk or severity of adverse effects can be increased when etodolac is combined with sulfasalazine.


The risk or severity of adverse effects can be increased when venlafaxine is combined with Levomilnacipran.


The risk or severity of adverse effects can be increased when selegiline is combined with ISOSORBIDE MONONITRATE.


The risk or severity of adverse effects can be increased when Efonidipine is combined with pramipexole.


The risk or severity of adverse effects can be increased when trimipramine is combined with ARBUTAMINE.


The risk or severity of adverse effects can be increased when VALPROIC ACID is combined with SERTINDOLE.


The risk or severity of adverse effects can be increased when Olopatadine is combined with Iloperidone.


The risk or severity of adverse effects can be increased when Ropivacaine is combined with scopolamine.


The risk or severity of adverse effects can be increased when Apremilast is combined with Fluticasone furoate.


The risk or severity of adverse effects can be increased when nicergoline is combined with irbesartan.


The risk or severity of adverse effects can be increased when diflorasone is combined with malathion.


The risk or severity of adverse effects can be increased when amobarbital is combined with METAXALONE.


The risk or severity of adverse effects can be increased when Oxybuprocaine is combined with amisulpride.


The risk or severity of adverse effects can be increased when imipramine is combined with Canagliflozin.


The risk or severity of adverse effects can be increased when zopiclone is combined with Agomelatine.


The risk or severity of adverse effects can be increased when morniflumate is combined with etodolac.


The risk or severity of adverse effects can be increased when clozapine is combined with penbutolol.


The risk or severity of adverse effects can be increased when morniflumate is combined with ZILEUTON.


The risk or severity of adverse effects can be increased when oxiconazole is combined with atorvastatin.


The risk or severity of adverse effects can be increased when clozapine is combined with Hexobarbital.


The risk or severity of adverse effects can be increased when benzocaine is combined with zotepine.


The risk or severity of adverse effects can be increased when benzocaine is combined with MELPERONE.


The risk or severity of adverse effects can be increased when clozapine is combined with amobarbital.


The risk or severity of adverse effects can be increased when nicergoline is combined with doxorubicin.


The risk or severity of adverse effects can be increased when thiopental is combined with SERTINDOLE.


The risk or severity of adverse effects can be increased when Oxybuprocaine is combined with benzocaine.


The risk or severity of adverse effects can be increased when buspirone is combined with vigabatrin.


The risk or severity of adverse effects can be increased when secobarbital is combined with cetirizine.


The risk or severity of adverse effects can be increased when tolmetin is combined with desoximetasone.


The risk or severity of adverse effects can be increased when Oxetacaine is combined with felbamate.


The risk or severity of adverse effects can be increased when Fluspirilene is combined with TRICHLOROETHYLENE.


The risk or severity of adverse effects can be increased when aspirin is combined with Lornoxicam.


The risk or severity of adverse effects can be increased when TASOSARTAN is combined with lisinopril.


The risk or severity of adverse effects can be increased when nitrazepam is combined with desipramine.


The risk or severity of adverse effects can be increased when nitrazepam is combined with thiamylal.


The risk or severity of adverse effects can be increased when pentobarbital is combined with Difenoxin.


The risk or severity of adverse effects can be increased when Choline magnesium trisalicylate is combined with estrone.


The risk or severity of adverse effects can be increased when Halazepam is combined with topiramate.


The risk or severity of adverse effects can be increased when nitrazepam is combined with halothane.


The risk or severity of adverse effects can be increased when Treprostinil is combined with indomethacin.


The risk or severity of adverse effects can be increased when diazepam is combined with VORTIOXETINE.


The risk or severity of adverse effects can be increased when propranolol is combined with Aliskiren.


The risk or severity of adverse effects can be increased when indomethacin is combined with Halobetasol.


The risk or severity of adverse effects can be increased when indomethacin is combined with FLUOCINOLONE ACETONIDE.


The risk or severity of adverse effects can be increased when benazepril is combined with flurbiprofen.


The risk or severity of adverse effects can be increased when ethchlorvynol is combined with Iloperidone.


The risk or severity of adverse effects can be increased when chlorthalidone is combined with ouabain.


The risk or severity of adverse effects can be increased when meperidine is combined with zaleplon.


The risk or severity of adverse effects can be increased when tranylcypromine is combined with cetirizine.


The risk or severity of adverse effects can be increased when alclofenac is combined with betamethasone.


The risk or severity of adverse effects can be increased when Eprosartan is combined with Telmisartan.


The risk or severity of adverse effects can be increased when Eprosartan is combined with apraclonidine.


The risk or severity of adverse effects can be increased when Propoxycaine is combined with Desloratadine.


The risk or severity of adverse effects can be increased when tropicamide is combined with HEROIN.


The risk or severity of adverse effects can be increased when Lornoxicam is combined with zaltoprofen.


The risk or severity of adverse effects can be increased when Lornoxicam is combined with Aceclofenac.


The risk or severity of adverse effects can be increased when SERTINDOLE is combined with METHSUXIMIDE.


The risk or severity of adverse effects can be increased when etodolac is combined with ETOFENAMATE.


The risk or severity of adverse effects can be increased when AZILSARTAN MEDOXOMIL is combined with captopril.


The risk or severity of adverse effects can be increased when isoflurane is combined with methoxyflurane.


The risk or severity of adverse effects can be increased when etodolac is combined with fenbufen.


The risk or severity of adverse effects can be increased when Torasemide is combined with irbesartan.


The risk or severity of adverse effects can be increased when tizanidine is combined with scopolamine.


The risk or severity of adverse effects can be increased when methocarbamol is combined with Difenoxin.


The risk or severity of adverse effects can be increased when thioridazine is combined with Fluspirilene.


The risk or severity of adverse effects can be increased when Torasemide is combined with felodipine.


The risk or severity of adverse effects can be increased when Torasemide is combined with ISOSORBIDE MONONITRATE.


The risk or severity of adverse effects can be increased when butabarbital is combined with sulpiride.


The risk or severity of adverse effects can be increased when butabarbital is combined with carisoprodol.


The risk or severity of adverse effects can be increased when Teriflunomide is combined with fenbufen.


The risk or severity of adverse effects can be increased when acebutolol is combined with Carbamylcholine.


The risk or severity of adverse effects can be increased when 4-Hydroxybutanoic acid is combined with procaine.


The risk or severity of adverse effects can be increased when RIMEXOLONE is combined with donepezil.


The risk or severity of adverse effects can be increased when dipyridamole is combined with hydralazine.


The risk or severity of adverse effects can be increased when estazolam is combined with Propoxycaine.


The risk or severity of adverse effects can be increased when nicergoline is combined with mirtazapine.


The risk or severity of adverse effects can be increased when fluvoxamine is combined with thiamylal.


The risk or severity of adverse effects can be increased when chlormezanone is combined with citalopram.


The risk or severity of adverse effects can be increased when diazepam is combined with Levomilnacipran.


The risk or severity of adverse effects can be increased when butabarbital is combined with benzyl alcohol.


The risk or severity of adverse effects can be increased when tiagabine is combined with desipramine.


The risk or severity of adverse effects can be increased when MOXONIDINE is combined with tretinoin.


The risk or severity of adverse effects can be increased when thiamylal is combined with Pomalidomide.


The risk or severity of adverse effects can be increased when meprobamate is combined with bromazepam.


The risk or severity of adverse effects can be increased when diazepam is combined with Pomalidomide.


The risk or severity of adverse effects can be increased when practolol is combined with Cevimeline.


The risk or severity of adverse effects can be increased when Perospirone is combined with meclizine.


The risk or severity of adverse effects can be increased when DEZOCINE is combined with Fluspirilene.


The risk or severity of adverse effects can be increased when enalapril is combined with cilazapril.


The risk or severity of adverse effects can be increased when minoxidil is combined with isoxsuprine.


The risk or severity of adverse effects can be increased when fenoprofen is combined with fludrocortisone.


The risk or severity of adverse effects can be increased when DEZOCINE is combined with TETRABENAZINE.


The risk or severity of adverse effects can be increased when tolnaftate is combined with nisoldipine.


The risk or severity of adverse effects can be increased when terazosin is combined with Pentyl nitrite.


The risk or severity of adverse effects can be increased when fenoprofen is combined with mycophenolate mofetil.


The risk or severity of adverse effects can be increased when Propacetamol is combined with Cis-mdp.


The risk or severity of adverse effects can be increased when Perospirone is combined with promethazine.


The risk or severity of adverse effects can be increased when Perospirone is combined with clonazepam.


The risk or severity of adverse effects can be increased when BECLOMETHASONE DIPROPIONATE is combined with enoxacin.


The risk or severity of adverse effects can be increased when triflupromazine is combined with CYPROHEPTADINE.


The risk or severity of adverse effects can be increased when ERGOTAMINE is combined with Quinine.


The risk or severity of adverse effects can be increased when nisoldipine is combined with hydrochlorothiazide.


The risk or severity of adverse effects can be increased when Tasimelteon is combined with Milnacipran.


The risk or severity of adverse effects can be increased when Ropivacaine is combined with terazosin.


The risk or severity of adverse effects can be increased when Nepafenac is combined with antipyrine.


The risk or severity of adverse effects can be increased when Tramadol is combined with procaine.


The risk or severity of adverse effects can be increased when tubocurarine is combined with codeine.


The risk or severity of adverse effects can be increased when pramipexole is combined with Eplerenone.


The risk or severity of adverse effects can be increased when butorphanol is combined with estazolam.


The risk or severity of adverse effects can be increased when sulfasalazine is combined with antipyrine.


The risk or severity of adverse effects can be increased when haloperidol is combined with midazolam.


The risk or severity of adverse effects can be increased when PRIMAQUINE is combined with NITROUS ACID.


The risk or severity of adverse effects can be increased when butorphanol is combined with dantrolene.


The risk or severity of adverse effects can be increased when chlorthalidone is combined with Nitroprusside.


The risk or severity of adverse effects can be increased when butabarbital is combined with desipramine.


The risk or severity of adverse effects can be increased when Fospropofol is combined with Propoxycaine.


The risk or severity of adverse effects can be increased when Fospropofol is combined with Pramocaine.


The risk or severity of adverse effects can be increased when chlorprothixene is combined with amoxapine.


The risk or severity of adverse effects can be increased when chlorprothixene is combined with nortriptyline.


The risk or severity of adverse effects can be increased when doxazosin is combined with Eprosartan.


The risk or severity of adverse effects can be increased when Butethal is combined with butamben.


The risk or severity of adverse effects can be increased when BENZYDAMINE is combined with Tixocortol.


The risk or severity of adverse effects can be increased when metolazone is combined with nadolol.


The risk or severity of adverse effects can be increased when oxprenolol is combined with furosemide.


The risk or severity of adverse effects can be increased when gabapentin is combined with methocarbamol.


The risk or severity of adverse effects can be increased when gabapentin is combined with triprolidine.


The risk or severity of adverse effects can be increased when bumetanide is combined with digoxin.


The risk or severity of adverse effects can be increased when bumetanide is combined with sulpiride.


The risk or severity of adverse effects can be increased when Masoprocol is combined with acemetacin.


The risk or severity of adverse effects can be increased when methadone is combined with HEROIN.


The risk or severity of adverse effects can be increased when ethchlorvynol is combined with Levomilnacipran.


The risk or severity of adverse effects can be increased when Oxybuprocaine is combined with methocarbamol.


The risk or severity of adverse effects can be increased when SUFENTANIL is combined with AZILSARTAN MEDOXOMIL.


The risk or severity of adverse effects can be increased when amobarbital is combined with brotizolam.


The risk or severity of adverse effects can be increased when Oxybuprocaine is combined with triprolidine.


The risk or severity of adverse effects can be increased when tretinoin is combined with Metipranolol.


The risk or severity of adverse effects can be increased when ethchlorvynol is combined with Pomalidomide.


The risk or severity of adverse effects can be increased when tretinoin is combined with LEVOBUNOLOL.


The risk or severity of adverse effects can be increased when chlordiazepoxide is combined with baclofen.


The risk or severity of adverse effects can be increased when flunarizine is combined with nefazodone.


The risk or severity of adverse effects can be increased when rescinnamine is combined with oxaprozin.


The risk or severity of adverse effects can be increased when DEXMEDETOMIDINE is combined with trazodone.


The risk or severity of adverse effects can be increased when chloroquine is combined with BENZYDAMINE.


The risk or severity of adverse effects can be increased when Ziprasidone is combined with enflurane.


The risk or severity of adverse effects can be increased when halcinonide is combined with Gemifloxacin.


The risk or severity of adverse effects can be increased when AZILSARTAN MEDOXOMIL is combined with flurbiprofen.


The risk or severity of adverse effects can be increased when nitrendipine is combined with acebutolol.


The risk or severity of adverse effects can be increased when DIPHENOXYLATE is combined with Efonidipine.


The risk or severity of adverse effects can be increased when hydromorphone is combined with Fospropofol.


The risk or severity of adverse effects can be increased when Lornoxicam is combined with halcinonide.


The risk or severity of adverse effects can be increased when betamethasone is combined with ROSOXACIN.


The risk or severity of adverse effects can be increased when medrysone is combined with tubocurarine.


The risk or severity of adverse effects can be increased when trifluoperazine is combined with Tasimelteon.


The risk or severity of adverse effects can be increased when REMIFENTANIL is combined with SERTINDOLE.


The risk or severity of adverse effects can be increased when Normethadone is combined with Alvimopan.


The risk or severity of adverse effects can be increased when benzyl alcohol is combined with tiagabine.


The risk or severity of adverse effects can be increased when duloxetine is combined with Aceprometazine.


The risk or severity of adverse effects can be increased when Carbetocin is combined with nitric oxide.


The risk or severity of adverse effects can be increased when Sacubitril is combined with Olopatadine.


The risk or severity of adverse effects can be increased when Carbetocin is combined with BENDROFLUMETHIAZIDE.


The risk or severity of adverse effects can be increased when Nepafenac is combined with etodolac.


The risk or severity of adverse effects can be increased when Ketobemidone is combined with Ramelteon.


The risk or severity of adverse effects can be increased when Clofarabine is combined with Empagliflozin.


The risk or severity of adverse effects can be increased when Nepafenac is combined with ZILEUTON.


The risk or severity of adverse effects can be increased when amifostine is combined with ESMOLOL.


The risk or severity of adverse effects can be increased when Nepafenac is combined with hydrocortisone.


The risk or severity of adverse effects can be increased when antipyrine is combined with oxyphenbutazone.


The risk or severity of adverse effects can be increased when Tapentadol is combined with chlorthalidone.


The risk or severity of adverse effects can be increased when Eprosartan is combined with Nebivolol.


The risk or severity of adverse effects can be increased when cocaine is combined with Fluspirilene.


The risk or severity of adverse effects can be increased when budesonide is combined with norfloxacin.


The risk or severity of adverse effects can be increased when propofol is combined with thiopental.


The risk or severity of adverse effects can be increased when budesonide is combined with Echothiophate.


The risk or severity of adverse effects can be increased when brimonidine is combined with ISOSORBIDE MONONITRATE.


The risk or severity of adverse effects can be increased when difluprednate is combined with Demecarium.


The risk or severity of adverse effects can be increased when nitrendipine is combined with propranolol.


The risk or severity of adverse effects can be increased when clarithromycin is combined with oxycodone.


The risk or severity of adverse effects can be increased when Arotinolol is combined with imipramine.


The risk or severity of adverse effects can be increased when pirenzepine is combined with morphine.


The risk or severity of adverse effects can be increased when nefazodone is combined with isocarboxazid.


The risk or severity of adverse effects can be increased when ALFENTANIL is combined with DIPHENOXYLATE.


The risk or severity of adverse effects can be increased when cyclobenzaprine is combined with Perospirone.


The risk or severity of adverse effects can be increased when sumatriptan is combined with MOLINDONE.


The risk or severity of adverse effects can be increased when chlormezanone is combined with Oxetacaine.


The risk or severity of adverse effects can be increased when clemastine is combined with CYPROHEPTADINE.


The risk or severity of adverse effects can be increased when buspirone is combined with methoxyflurane.


The risk or severity of adverse effects can be increased when Benidipine is combined with pravastatin.


The risk or severity of adverse effects can be increased when EFINACONAZOLE is combined with nicardipine.


The risk or severity of adverse effects can be increased when antipyrine is combined with FLUTICASONE PROPIONATE.


The risk or severity of adverse effects can be increased when amiodarone is combined with isoxsuprine.


The risk or severity of adverse effects can be increased when Pirlindole is combined with methadone.


The risk or severity of adverse effects can be increased when nitric oxide is combined with phenobarbital.


The risk or severity of adverse effects can be increased when tretinoin is combined with hydralazine.


The risk or severity of adverse effects can be increased when diflunisal is combined with fludrocortisone.


The risk or severity of adverse effects can be increased when paramethasone is combined with memantine.


The risk or severity of adverse effects can be increased when paramethasone is combined with Gatifloxacin.


The risk or severity of adverse effects can be increased when meclofenamic acid is combined with oxaprozin.


The risk or severity of adverse effects can be increased when quinapril is combined with carvedilol.


The risk or severity of adverse effects can be increased when Zuclopenthixol is combined with etizolam.


The risk or severity of adverse effects can be increased when clonidine is combined with maprotiline.


The risk or severity of adverse effects can be increased when thalidomide is combined with MOEXIPRIL.


The risk or severity of adverse effects can be increased when nitric oxide is combined with ISOSORBIDE DINITRATE.


The risk or severity of adverse effects can be increased when nitric oxide is combined with quinapril.


The risk or severity of adverse effects can be increased when nitric oxide is combined with chlorothiazide.


The risk or severity of adverse effects can be increased when Carbetocin is combined with morphine.


The risk or severity of adverse effects can be increased when methocarbamol is combined with vigabatrin.


The risk or severity of adverse effects can be increased when Carbetocin is combined with Ropivacaine.


The risk or severity of adverse effects can be increased when dobutamine is combined with clenbuterol.


The risk or severity of adverse effects can be increased when bromocriptine is combined with lansoprazole.


The risk or severity of adverse effects can be increased when bromocriptine is combined with chloramphenicol.


The risk or severity of adverse effects can be increased when buprenorphine is combined with methazolamide.


The risk or severity of adverse effects can be increased when bromocriptine is combined with teniposide.


The risk or severity of adverse effects can be increased when bromocriptine is combined with betamethasone.


The risk or severity of adverse effects can be increased when pentazocine is combined with zotepine.


The risk or severity of adverse effects can be increased when pentazocine is combined with MELPERONE.


The risk or severity of adverse effects can be increased when niflumic acid is combined with flumethasone.


The risk or severity of adverse effects can be increased when diazepam is combined with flunarizine.


The risk or severity of adverse effects can be increased when thiothixene is combined with Etidocaine.


The risk or severity of adverse effects can be increased when Masoprocol is combined with Ibandronic Acid.


The risk or severity of adverse effects can be increased when Saxagliptin is combined with enalapril.


The risk or severity of adverse effects can be increased when nisoldipine is combined with prazosin.


The risk or severity of adverse effects can be increased when DEXMEDETOMIDINE is combined with scopolamine.


The risk or severity of adverse effects can be increased when chloral hydrate is combined with SERTINDOLE.


The risk or severity of adverse effects can be increased when felodipine is combined with MAGNESIUM OXIDE.


The risk or severity of adverse effects can be increased when sulfamethoxazole is combined with atorvastatin.


The risk or severity of adverse effects can be increased when nitrous oxide is combined with benzyl alcohol.


The risk or severity of adverse effects can be increased when oxaprozin is combined with amcinonide.


The risk or severity of adverse effects can be increased when hydrochlorothiazide is combined with irbesartan.


The risk or severity of adverse effects can be increased when oxprenolol is combined with protriptyline.


The risk or severity of adverse effects can be increased when flunitrazepam is combined with Gabapentin enacarbil.


The risk or severity of adverse effects can be increased when fenoprofen is combined with Tenofovir disoproxil.


The risk or severity of adverse effects can be increased when oxaprozin is combined with PAMIDRONIC ACID.


The risk or severity of adverse effects can be increased when secobarbital is combined with Pramocaine.


The risk or severity of adverse effects can be increased when hydrochlorothiazide is combined with ISOSORBIDE MONONITRATE.


The risk or severity of adverse effects can be increased when secobarbital is combined with Propoxycaine.


The risk or severity of adverse effects can be increased when haloperidol is combined with Methadyl acetate.


The risk or severity of adverse effects can be increased when alprazolam is combined with clonazepam.


The risk or severity of adverse effects can be increased when alprazolam is combined with promethazine.


The risk or severity of adverse effects can be increased when perphenazine is combined with doxepin.


The risk or severity of adverse effects can be increased when Estrone sulfate is combined with ambenonium.


The risk or severity of adverse effects can be increased when minoxidil is combined with DEXMEDETOMIDINE.


The risk or severity of adverse effects can be increased when alprazolam is combined with Melatonin.


The risk or severity of adverse effects can be increased when nisoldipine is combined with MOEXIPRIL.


The risk or severity of adverse effects can be increased when methysergide is combined with sulfinpyrazone.


The risk or severity of adverse effects can be increased when nisoldipine is combined with furosemide.


The risk or severity of adverse effects can be increased when NAPROXEN is combined with Dehydroepiandrosterone.


The risk or severity of adverse effects can be increased when Halazepam is combined with Fosphenytoin.


The risk or severity of adverse effects can be increased when Pimecrolimus is combined with CORTISONE ACETATE.


The risk or severity of adverse effects can be increased when oxazepam is combined with flunitrazepam.


The risk or severity of adverse effects can be increased when alprazolam is combined with olanzapine.


The risk or severity of adverse effects can be increased when hydromorphone is combined with DESFLURANE.


The risk or severity of adverse effects can be increased when cilazapril is combined with Nepafenac.


The risk or severity of adverse effects can be increased when meperidine is combined with Articaine.


The risk or severity of adverse effects can be increased when oxymorphone is combined with fludiazepam.


The risk or severity of adverse effects can be increased when imipramine is combined with Dapagliflozin.


The risk or severity of adverse effects can be increased when meperidine is combined with Cyamemazine.


The risk or severity of adverse effects can be increased when Olopatadine is combined with Pizotifen.


The risk or severity of adverse effects can be increased when tetrahydrozoline is combined with PSEUDOEPHEDRINE.


The risk or severity of adverse effects can be increased when reserpine is combined with Fencamfamin.


The risk or severity of adverse effects can be increased when chlorothiazide is combined with methyldopa.


The risk or severity of adverse effects can be increased when Saxagliptin is combined with rescinnamine.


The risk or severity of adverse effects can be increased when levorphanol is combined with amitriptyline.


The risk or severity of adverse effects can be increased when levorphanol is combined with Tolcapone.


The risk or severity of adverse effects can be increased when METAXALONE is combined with Iloperidone.


The risk or severity of adverse effects can be increased when flurazepam is combined with Dexbrompheniramine.


The risk or severity of adverse effects can be increased when reserpine is combined with Ethylmorphine.


The risk or severity of adverse effects can be increased when flurazepam is combined with Remoxipride.


The risk or severity of adverse effects can be increased when Conivaptan is combined with Pipamperone.


The risk or severity of adverse effects can be increased when salicylic acid is combined with xylometazoline.


The risk or severity of adverse effects can be increased when benztropine is combined with oxyphenonium.


The risk or severity of adverse effects can be increased when theophylline is combined with formoterol.


The risk or severity of adverse effects can be increased when NATAMYCIN is combined with cilnidipine.


The risk or severity of adverse effects can be increased when glutethimide is combined with butamben.


The risk or severity of adverse effects can be increased when amphotericin b is combined with isradipine.


The risk or severity of adverse effects can be increased when BALSALAZIDE is combined with flumethasone.


The risk or severity of adverse effects can be increased when amphotericin b is combined with Olmesartan.


The risk or severity of adverse effects can be increased when sevoflurane is combined with Retigabine.


The risk or severity of adverse effects can be increased when NATAMYCIN is combined with Azelnidipine.


The risk or severity of adverse effects can be increased when indomethacin is combined with zaltoprofen.


The risk or severity of adverse effects can be increased when trazodone is combined with ethotoin.


The risk or severity of adverse effects can be increased when BALSALAZIDE is combined with Estrone sulfate.


The risk or severity of adverse effects can be increased when trazodone is combined with prilocaine.


The risk or severity of adverse effects can be increased when alprenolol is combined with Carbamylcholine.


The risk or severity of adverse effects can be increased when dexamethasone is combined with norfloxacin.


The risk or severity of adverse effects can be increased when dexamethasone is combined with Echothiophate.


The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Ibrutinib.


The risk or severity of adverse effects can be increased when mycophenolate mofetil is combined with medrysone.


The risk or severity of adverse effects can be increased when Miltefosine is combined with eperisone.


The risk or severity of adverse effects can be increased when morphine is combined with triamterene.


The risk or severity of adverse effects can be increased when zaleplon is combined with fludiazepam.


The risk or severity of adverse effects can be increased when AZILSARTAN MEDOXOMIL is combined with acemetacin.


The risk or severity of adverse effects can be increased when Phenelzine is combined with naratriptan.


The risk or severity of adverse effects can be increased when griseofulvin is combined with eperisone.


The risk or severity of adverse effects can be increased when cilnidipine is combined with Pipamperone.


The risk or severity of adverse effects can be increased when thiamylal is combined with Desloratadine.


The risk or severity of adverse effects can be increased when ANISOTROPINE METHYLBROMIDE is combined with methscopolamine.


The risk or severity of adverse effects can be increased when glutethimide is combined with BREXPIPRAZOLE.


The risk or severity of adverse effects can be increased when chlordiazepoxide is combined with 4-Hydroxybutanoic acid.


The risk or severity of adverse effects can be increased when proparacaine is combined with Fosphenytoin.


The risk or severity of adverse effects can be increased when Methadyl acetate is combined with Flibanserin.


The risk or severity of adverse effects can be increased when terazosin is combined with Clevidipine.


The risk or severity of adverse effects can be increased when irbesartan is combined with Dapagliflozin.


The risk or severity of adverse effects can be increased when Posaconazole is combined with flunarizine.


The risk or severity of adverse effects can be increased when sulfasalazine is combined with homoharringtonine.


The risk or severity of adverse effects can be increased when Fospropofol is combined with desipramine.


The risk or severity of adverse effects can be increased when morphine is combined with DESMOPRESSIN.


The risk or severity of adverse effects can be increased when tolazoline is combined with methyclothiazide.


The risk or severity of adverse effects can be increased when nisoldipine is combined with metolazone.


The risk or severity of adverse effects can be increased when thiopental is combined with Tolcapone.


The risk or severity of adverse effects can be increased when oxaprozin is combined with Etoricoxib.


The risk or severity of adverse effects can be increased when reserpine is combined with brotizolam.


The risk or severity of adverse effects can be increased when nisoldipine is combined with Nebivolol.


The risk or severity of adverse effects can be increased when NAPROXEN is combined with homoharringtonine.


The risk or severity of adverse effects can be increased when Dothiepin is combined with metaproterenol.


The risk or severity of adverse effects can be increased when pancuronium is combined with SUFENTANIL.


The risk or severity of adverse effects can be increased when quazepam is combined with Oxetacaine.


The risk or severity of adverse effects can be increased when equilin is combined with Deferasirox.


The risk or severity of adverse effects can be increased when Ketobemidone is combined with tiapride.


The risk or severity of adverse effects can be increased when Lercanidipine is combined with Clevidipine.


The risk or severity of adverse effects can be increased when Eletriptan is combined with Paliperidone.


The risk or severity of adverse effects can be increased when chloral hydrate is combined with Milnacipran.


The risk or severity of adverse effects can be increased when floctafenine is combined with homoharringtonine.


The risk or severity of adverse effects can be increased when cetirizine is combined with amoxapine.


The risk or severity of adverse effects can be increased when CHLOROPROCAINE is combined with oxprenolol.


The risk or severity of adverse effects can be increased when tolmetin is combined with Cis-mdp.


The risk or severity of adverse effects can be increased when Mometasone is combined with ROSOXACIN.


The risk or severity of adverse effects can be increased when azelastine is combined with loteprednol.


The risk or severity of adverse effects can be increased when ILOPROST is combined with ropinirole.


The risk or severity of adverse effects can be increased when lorazepam is combined with SERTINDOLE.


The risk or severity of adverse effects can be increased when Nitroprusside is combined with hydrochlorothiazide.


The risk or severity of adverse effects can be increased when cilnidipine is combined with MAGNESIUM OXIDE.


The risk or severity of adverse effects can be increased when amoxapine is combined with Salbutamol.


The risk or severity of adverse effects can be increased when dibucaine is combined with meclizine.


The risk or severity of adverse effects can be increased when etizolam is combined with butamben.


The risk or severity of adverse effects can be increased when methysergide is combined with quinidine.


The risk or severity of adverse effects can be increased when zopiclone is combined with etizolam.


The risk or severity of adverse effects can be increased when reserpine is combined with Agomelatine.


The risk or severity of adverse effects can be increased when thiothixene is combined with dibucaine.


The risk or severity of adverse effects can be increased when Pimecrolimus is combined with acemetacin.


The risk or severity of adverse effects can be increased when chlorprothixene is combined with fexofenadine.


The risk or severity of adverse effects can be increased when argatroban is combined with cyclophosphamide.


The risk or severity of adverse effects can be increased when Etidocaine is combined with protriptyline.


The risk or severity of adverse effects can be increased when Etidocaine is combined with cetirizine.


The risk or severity of adverse effects can be increased when fenoldopam is combined with propofol.


The risk or severity of adverse effects can be increased when AMILORIDE is combined with irbesartan.


The risk or severity of adverse effects can be increased when Paliperidone is combined with Normethadone.


The risk or severity of adverse effects can be increased when haloperidol is combined with Desloratadine.


The risk or severity of adverse effects can be increased when tacrolimus is combined with mechlorethamine.


The risk or severity of adverse effects can be increased when imipramine is combined with valsartan.


The risk or severity of adverse effects can be increased when rasagiline is combined with LEVOBUNOLOL.


The risk or severity of adverse effects can be increased when Lormetazepam is combined with fexofenadine.


The risk or severity of adverse effects can be increased when docetaxel is combined with Dexrazoxane.


The risk or severity of adverse effects can be increased when Talniflumate is combined with Salsalate.


The risk or severity of adverse effects can be increased when DEFLAZACORT is combined with memantine.


The risk or severity of adverse effects can be increased when DEFLAZACORT is combined with Gatifloxacin.


The risk or severity of adverse effects can be increased when codeine is combined with carisoprodol.


The risk or severity of adverse effects can be increased when trazodone is combined with thiamylal.


The risk or severity of adverse effects can be increased when BREXPIPRAZOLE is combined with methylphenidate.


The risk or severity of adverse effects can be increased when Talniflumate is combined with Magnesium salicylate.


The risk or severity of adverse effects can be increased when MOEXIPRIL is combined with cilazapril.


The risk or severity of adverse effects can be increased when rizatriptan is combined with BREXPIPRAZOLE.


The risk or severity of adverse effects can be increased when Nitroprusside is combined with irbesartan.


The risk or severity of adverse effects can be increased when Asenapine is combined with chlorzoxazone.


The risk or severity of adverse effects can be increased when procarbazine is combined with Thioproperazine.


The risk or severity of adverse effects can be increased when Candesartan cilexetil is combined with dichlorphenamide.


The risk or severity of adverse effects can be increased when Nitroprusside is combined with ISOSORBIDE MONONITRATE.


The risk or severity of adverse effects can be increased when hydromorphone is combined with DEXMEDETOMIDINE.


The risk or severity of adverse effects can be increased when ESMOLOL is combined with D-mannitol.


The risk or severity of adverse effects can be increased when carprofen is combined with Zoledronic acid.


The risk or severity of adverse effects can be increased when carprofen is combined with BECLOMETHASONE DIPROPIONATE.


The risk or severity of adverse effects can be increased when Nitroprusside is combined with timolol.


The risk or severity of adverse effects can be increased when Bortezomib is combined with D-mannitol.


The risk or severity of adverse effects can be increased when cyclopentolate is combined with dicyclomine.


The risk or severity of adverse effects can be increased when propofol is combined with trifluoperazine.


The risk or severity of adverse effects can be increased when Micafungin is combined with tolfenamic acid.


The risk or severity of adverse effects can be increased when PERHEXILINE is combined with MAGNESIUM OXIDE.


The risk or severity of adverse effects can be increased when isoflurane is combined with felbamate.


The risk or severity of adverse effects can be increased when Lurasidone is combined with Butethal.


The risk or severity of adverse effects can be increased when Paliperidone is combined with CYPROHEPTADINE.


The risk or severity of adverse effects can be increased when Lurasidone is combined with Hexobarbital.


The risk or severity of adverse effects can be increased when Naftifine is combined with Apremilast.


The risk or severity of adverse effects can be increased when cilnidipine is combined with spironolactone.


The risk or severity of adverse effects can be increased when timolol is combined with spironolactone.


The risk or severity of adverse effects can be increased when lorazepam is combined with METAXALONE.


The risk or severity of adverse effects can be increased when fenoldopam is combined with dichlorphenamide.


The risk or severity of adverse effects can be increased when carprofen is combined with Etoricoxib.


The risk or severity of adverse effects can be increased when Nabilone is combined with propranolol.


The risk or severity of adverse effects can be increased when dyclonine is combined with Tasimelteon.


The risk or severity of adverse effects can be increased when amoxapine is combined with ethotoin.


The risk or severity of adverse effects can be increased when Efonidipine is combined with papaverine.


The risk or severity of adverse effects can be increased when nimesulide is combined with mesalamine.


The risk or severity of adverse effects can be increased when nimesulide is combined with alclometasone.


The risk or severity of adverse effects can be increased when Efonidipine is combined with nifedipine.


The risk or severity of adverse effects can be increased when duloxetine is combined with Perospirone.


The risk or severity of adverse effects can be increased when isoflurane is combined with fosinopril.


The risk or severity of adverse effects can be increased when dibucaine is combined with Butethal.


The risk or severity of adverse effects can be increased when dibucaine is combined with Hexobarbital.


The risk or severity of adverse effects can be increased when dibucaine is combined with lithium ion.


The risk or severity of adverse effects can be increased when FLUPHENAZINE is combined with Pramocaine.


The risk or severity of adverse effects can be increased when enflurane is combined with dibucaine.


The risk or severity of adverse effects can be increased when dipyridamole is combined with aspirin.


The risk or severity of adverse effects can be increased when diphenhydramine is combined with felbamate.


The risk or severity of adverse effects can be increased when ATROPINE is combined with Trospium.


The risk or severity of adverse effects can be increased when nitrendipine is combined with Rotigotine.


The risk or severity of adverse effects can be increased when timolol is combined with nimodipine.


The risk or severity of adverse effects can be increased when benazepril is combined with antipyrine.


The risk or severity of adverse effects can be increased when tizanidine is combined with Telmisartan.


The risk or severity of adverse effects can be increased when butalbital is combined with chlorzoxazone.


The risk or severity of adverse effects can be increased when ketamine is combined with Aceprometazine.


The risk or severity of adverse effects can be increased when tizanidine is combined with methyldopa.


The risk or severity of adverse effects can be increased when ketamine is combined with MOLINDONE.


The risk or severity of adverse effects can be increased when Ropivacaine is combined with Etidocaine.


The risk or severity of adverse effects can be increased when DEZOCINE is combined with polythiazide.


The risk or severity of adverse effects can be increased when Ibrutinib is combined with ethyl icosapentate.


The risk or severity of adverse effects can be increased when nitrazepam is combined with benzyl alcohol.


The risk or severity of adverse effects can be increased when cabergoline is combined with PRIMAQUINE.


The risk or severity of adverse effects can be increased when brotizolam is combined with butamben.


The risk or severity of adverse effects can be increased when Ziprasidone is combined with Aceprometazine.


The risk or severity of adverse effects can be increased when cabergoline is combined with pilocarpine.


The risk or severity of adverse effects can be increased when fenoldopam is combined with Sacubitril.


The risk or severity of adverse effects can be increased when methylprednisolone is combined with norfloxacin.


The risk or severity of adverse effects can be increased when methyclothiazide is combined with Riociguat.


The risk or severity of adverse effects can be increased when cilnidipine is combined with Lofexidine.


The risk or severity of adverse effects can be increased when resveratrol is combined with Risedronic acid.


The risk or severity of adverse effects can be increased when isocarboxazid is combined with Cyamemazine.


The risk or severity of adverse effects can be increased when Lurasidone is combined with Remoxipride.


The risk or severity of adverse effects can be increased when trifluoperazine is combined with Paliperidone.


The risk or severity of adverse effects can be increased when floctafenine is combined with fenoprofen.


The risk or severity of adverse effects can be increased when PIRFENIDONE is combined with estrone.


The risk or severity of adverse effects can be increased when Lurasidone is combined with Dexbrompheniramine.


The risk or severity of adverse effects can be increased when trimetrexate is combined with diltiazem.


The risk or severity of adverse effects can be increased when methylphenidate is combined with cyclobenzaprine.


The risk or severity of adverse effects can be increased when Spirapril is combined with epirizole.


The risk or severity of adverse effects can be increased when fosinopril is combined with Olopatadine.


The risk or severity of adverse effects can be increased when oxycodone is combined with scopolamine.


The risk or severity of adverse effects can be increased when nimesulide is combined with DEFLAZACORT.


The risk or severity of adverse effects can be increased when Cangrelor is combined with aspirin.


The risk or severity of adverse effects can be increased when triazolam is combined with Pomalidomide.


The risk or severity of adverse effects can be increased when Aripiprazole is combined with VALPROIC ACID.


The risk or severity of adverse effects can be increased when procaine is combined with Fospropofol.


The risk or severity of adverse effects can be increased when dobutamine is combined with Ephedrine.


The risk or severity of adverse effects can be increased when propofol is combined with Riociguat.


The risk or severity of adverse effects can be increased when dobutamine is combined with PROCATEROL.


The risk or severity of adverse effects can be increased when acemetacin is combined with flunisolide.


The risk or severity of adverse effects can be increased when diphenhydramine is combined with tiapride.


The risk or severity of adverse effects can be increased when nilvadipine is combined with spironolactone.


The risk or severity of adverse effects can be increased when methylergonovine is combined with nifedipine.


The risk or severity of adverse effects can be increased when Almotriptan is combined with bromocriptine.


The risk or severity of adverse effects can be increased when secobarbital is combined with DESFLURANE.


The risk or severity of adverse effects can be increased when ketamine is combined with quetiapine.


The risk or severity of adverse effects can be increased when tropicamide is combined with oxycodone.


The risk or severity of adverse effects can be increased when Gabapentin enacarbil is combined with BREXPIPRAZOLE.


The risk or severity of adverse effects can be increased when chloral hydrate is combined with Dexbrompheniramine.


The risk or severity of adverse effects can be increased when Miltefosine is combined with Pregabalin.


The risk or severity of adverse effects can be increased when Normethadone is combined with Olopatadine.


The risk or severity of adverse effects can be increased when secobarbital is combined with FLUTICASONE PROPIONATE.


The risk or severity of adverse effects can be increased when haloperidol is combined with methylphenidate.


The risk or severity of adverse effects can be increased when haloperidol is combined with methocarbamol.


The risk or severity of adverse effects can be increased when prochlorperazine is combined with Paliperidone.


The risk or severity of adverse effects can be increased when haloperidol is combined with triprolidine.


The risk or severity of adverse effects can be increased when buspirone is combined with Tasimelteon.


The risk or severity of adverse effects can be increased when BALSALAZIDE is combined with dexamethasone.


The risk or severity of adverse effects can be increased when fosinopril is combined with acebutolol.


The risk or severity of adverse effects can be increased when VALPROIC ACID is combined with zotepine.


The risk or severity of adverse effects can be increased when temazepam is combined with Fencamfamin.


The risk or severity of adverse effects can be increased when butabarbital is combined with SERTINDOLE.


The risk or severity of adverse effects can be increased when temazepam is combined with Ethylmorphine.


The risk or severity of adverse effects can be increased when DIHYDROCODEINE is combined with indapamide.


The risk or severity of adverse effects can be increased when galanthamine is combined with Cevimeline.


The risk or severity of adverse effects can be increased when galanthamine is combined with nicotine.


The risk or severity of adverse effects can be increased when DIHYDROCODEINE is combined with Halazepam.


The risk or severity of adverse effects can be increased when DIHYDROCODEINE is combined with proparacaine.


The risk or severity of adverse effects can be increased when oxymorphone is combined with Torasemide.


The risk or severity of adverse effects can be increased when FLUTICASONE PROPIONATE is combined with flunarizine.


The risk or severity of adverse effects can be increased when Icatibant is combined with diflorasone.


The risk or severity of adverse effects can be increased when glutethimide is combined with Pipamperone.


The risk or severity of adverse effects can be increased when cilazapril is combined with suprofen.


The risk or severity of adverse effects can be increased when prilocaine is combined with butamben.


The risk or severity of adverse effects can be increased when enflurane is combined with Pramocaine.


The risk or severity of adverse effects can be increased when SUFENTANIL is combined with zonisamide.


The risk or severity of adverse effects can be increased when enflurane is combined with Propoxycaine.


The risk or severity of adverse effects can be increased when SUFENTANIL is combined with ondansetron.


The risk or severity of adverse effects can be increased when SUFENTANIL is combined with cocaine.


The risk or severity of adverse effects can be increased when SUFENTANIL is combined with tiagabine.


The risk or severity of adverse effects can be increased when SUFENTANIL is combined with ETHACRYNIC ACID.


The risk or severity of adverse effects can be increased when ETOFENAMATE is combined with Fluprednidene.


The risk or severity of adverse effects can be increased when ETOFENAMATE is combined with FLUOCORTOLONE.


The risk or severity of adverse effects can be increased when lidocaine is combined with dibucaine.


The risk or severity of adverse effects can be increased when codeine is combined with flunitrazepam.


The risk or severity of adverse effects can be increased when phenmetrazine is combined with tetrahydrozoline.


The risk or severity of adverse effects can be increased when carisoprodol is combined with Difenoxin.


The risk or severity of adverse effects can be increased when sulpiride is combined with loratadine.


The risk or severity of adverse effects can be increased when Pipamperone is combined with Canagliflozin.


The risk or severity of adverse effects can be increased when dicyclomine is combined with topiramate.


The risk or severity of adverse effects can be increased when Teriflunomide is combined with FLUOCINOLONE ACETONIDE.


The risk or severity of adverse effects can be increased when nimesulide is combined with acemetacin.


The risk or severity of adverse effects can be increased when benztropine is combined with cyclopentolate.


The risk or severity of adverse effects can be increased when promethazine is combined with periciazine.


The risk or severity of adverse effects can be increased when DESFLURANE is combined with topiramate.


The risk or severity of adverse effects can be increased when tiaprofenic acid is combined with Ibandronic Acid.


The risk or severity of adverse effects can be increased when DESFLURANE is combined with isradipine.


The risk or severity of adverse effects can be increased when Normethadone is combined with baclofen.


The risk or severity of adverse effects can be increased when scopolamine is combined with Levetiracetam.


The risk or severity of adverse effects can be increased when rasagiline is combined with dipyridamole.


The risk or severity of adverse effects can be increased when phenobarbital is combined with Fluspirilene.


The risk or severity of adverse effects can be increased when Lurasidone is combined with glutethimide.


The risk or severity of adverse effects can be increased when Remoxipride is combined with vigabatrin.


The risk or severity of adverse effects can be increased when promazine is combined with etizolam.


The risk or severity of adverse effects can be increased when Lurasidone is combined with Methadyl acetate.


The risk or severity of adverse effects can be increased when tolnaftate is combined with nifedipine.


The risk or severity of adverse effects can be increased when Anidulafungin is combined with PERHEXILINE.


The risk or severity of adverse effects can be increased when Remoxipride is combined with benzocaine.


The risk or severity of adverse effects can be increased when butabarbital is combined with clorazepate.


The risk or severity of adverse effects can be increased when midazolam is combined with loratadine.


The risk or severity of adverse effects can be increased when labetalol is combined with methazolamide.


The risk or severity of adverse effects can be increased when labetalol is combined with Eplerenone.


The risk or severity of adverse effects can be increased when butabarbital is combined with FLUPHENAZINE.


The risk or severity of adverse effects can be increased when midazolam is combined with imipramine.


The risk or severity of adverse effects can be increased when zaleplon is combined with Levobupivacaine.


The risk or severity of adverse effects can be increased when butabarbital is combined with efavirenz.


The risk or severity of adverse effects can be increased when temazepam is combined with olanzapine.


The risk or severity of adverse effects can be increased when nitrazepam is combined with Gabapentin enacarbil.


The risk or severity of adverse effects can be increased when DEZOCINE is combined with trimipramine.


The risk or severity of adverse effects can be increased when nabumetone is combined with difluprednate.


The risk or severity of adverse effects can be increased when epinephrine is combined with dopamine.


The risk or severity of adverse effects can be increased when chloral hydrate is combined with efavirenz.


The risk or severity of adverse effects can be increased when Masoprocol is combined with ALENDRONIC ACID.


The risk or severity of adverse effects can be increased when estazolam is combined with Olopatadine.


The risk or severity of adverse effects can be increased when ramipril is combined with antipyrine.


The risk or severity of adverse effects can be increased when midazolam is combined with Perospirone.


The risk or severity of adverse effects can be increased when spironolactone is combined with methazolamide.


The risk or severity of adverse effects can be increased when amisulpride is combined with amitriptyline.


The risk or severity of adverse effects can be increased when baclofen is combined with Desloratadine.


The risk or severity of adverse effects can be increased when Aripiprazole is combined with Pizotifen.


The risk or severity of adverse effects can be increased when VALPROIC ACID is combined with ethyl loflazepate.


The risk or severity of adverse effects can be increased when clozapine is combined with chlorthalidone.


The risk or severity of adverse effects can be increased when clozapine is combined with VALPROIC ACID.


The risk or severity of adverse effects can be increased when bupivacaine is combined with Eprosartan.


The risk or severity of adverse effects can be increased when tolnaftate is combined with nimodipine.


The risk or severity of adverse effects can be increased when bromocriptine is combined with cilazapril.


The risk or severity of adverse effects can be increased when dicyclomine is combined with oxycodone.


The risk or severity of adverse effects can be increased when LEVOSIMENDAN is combined with Canagliflozin.


The risk or severity of adverse effects can be increased when butabarbital is combined with VORTIOXETINE.


The risk or severity of adverse effects can be increased when cilazapril is combined with ibuprofen.


The risk or severity of adverse effects can be increased when chloramphenicol is combined with ethanol.


The risk or severity of adverse effects can be increased when Levetiracetam is combined with citalopram.


The risk or severity of adverse effects can be increased when DESFLURANE is combined with Oxybuprocaine.


The risk or severity of adverse effects can be increased when Bortezomib is combined with AMILORIDE.


The risk or severity of adverse effects can be increased when fludiazepam is combined with paroxetine.


The risk or severity of adverse effects can be increased when ATROPINE is combined with quinidine.


The risk or severity of adverse effects can be increased when perphenazine is combined with amoxapine.


The risk or severity of adverse effects can be increased when pergolide is combined with mefloquine.


The risk or severity of adverse effects can be increased when chlorthalidone is combined with tizanidine.


The risk or severity of adverse effects can be increased when chlorthalidone is combined with furosemide.


The risk or severity of adverse effects can be increased when zolmitriptan is combined with mirtazapine.


The risk or severity of adverse effects can be increased when Fosamprenavir is combined with cyclophosphamide.


The risk or severity of adverse effects can be increased when pergolide is combined with chlorzoxazone.


The risk or severity of adverse effects can be increased when tiaprofenic acid is combined with fluocinonide.


The risk or severity of adverse effects can be increased when BENDROFLUMETHIAZIDE is combined with furosemide.


The risk or severity of adverse effects can be increased when quinapril is combined with tenoxicam.


The risk or severity of adverse effects can be increased when BENDROFLUMETHIAZIDE is combined with tizanidine.


The risk or severity of adverse effects can be increased when BENDROFLUMETHIAZIDE is combined with MOEXIPRIL.


The risk or severity of adverse effects can be increased when chlorzoxazone is combined with scopolamine.


The risk or severity of adverse effects can be increased when nystatin is combined with VERAPAMIL.


The risk or severity of adverse effects can be increased when Ciclesonide is combined with mefloquine.


The risk or severity of adverse effects can be increased when risperidone is combined with zaleplon.


The risk or severity of adverse effects can be increased when quinapril is combined with nabumetone.


The risk or severity of adverse effects can be increased when Tramadol is combined with enflurane.


The risk or severity of adverse effects can be increased when risperidone is combined with mepivacaine.


The risk or severity of adverse effects can be increased when quinapril is combined with ketorolac.


The risk or severity of adverse effects can be increased when nicergoline is combined with irinotecan.


The risk or severity of adverse effects can be increased when nicergoline is combined with methimazole.


The risk or severity of adverse effects can be increased when VORTIOXETINE is combined with trimipramine.


The risk or severity of adverse effects can be increased when DIPHENOXYLATE is combined with imipramine.


The risk or severity of adverse effects can be increased when sevoflurane is combined with Gabapentin enacarbil.


The risk or severity of adverse effects can be increased when DIPHENOXYLATE is combined with loratadine.


The risk or severity of adverse effects can be increased when ketamine is combined with meclizine.


The risk or severity of adverse effects can be increased when estazolam is combined with protriptyline.


The risk or severity of adverse effects can be increased when nalbuphine is combined with Fencamfamin.


The risk or severity of adverse effects can be increased when paroxetine is combined with desipramine.


The risk or severity of adverse effects can be increased when estazolam is combined with cetirizine.


The risk or severity of adverse effects can be increased when tioconazole is combined with MAGNESIUM SULFATE.


The risk or severity of adverse effects can be increased when haloperidol is combined with ketamine.


The risk or severity of adverse effects can be increased when halcinonide is combined with malathion.